Terms: = Colorectal cancer AND MAP3K1, ENSG00000095015, 4214, Q13233, MEKK1, MEKK, MAPKKK1 AND Treatment
4 results:
1. RNA-binding protein IMP3 is a novel regulator of MEK1/ERK signaling pathway in the progression of colorectal cancer through the stabilization of mekk1 mRNA.
Zhang M; Zhao S; Tan C; Gu Y; He X; Du X; Li D; Wei P
J Exp Clin Cancer Res; 2021 Jun; 40(1):200. PubMed ID: 34154626
[TBL] [Abstract] [Full Text] [Related]
2. Racial variation in willingness to trade financial resources for life-prolonging cancer treatment.
Martin MY; Pisu M; Oster RA; Urmie JM; Schrag D; Huskamp HA; Lee J; Kiefe CI; Fouad MN
Cancer; 2011 Aug; 117(15):3476-84. PubMed ID: 21523759
[TBL] [Abstract] [Full Text] [Related]
3. Ethnic disparity in mortality after diagnosis of colorectal cancer among inner city minority New Yorkers.
Kanna B; Narang TK; Atwal T; Paul D; Azeez S
Cancer; 2009 Dec; 115(23):5550-5. PubMed ID: 19823980
[TBL] [Abstract] [Full Text] [Related]
4. Alternative activation of extracellular signal-regulated protein kinases in curcumin and arsenite-induced HSP70 gene expression in human colorectal carcinoma cells.
Chen YC; Tsai SH; Shen SC; Lin JK; Lee WR
Eur J Cell Biol; 2001 Mar; 80(3):213-21. PubMed ID: 11322385
[TBL] [Abstract] [Full Text] [Related]
